Indications
Therapeutic Asset Ratings
9,922 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Ureter Transitional Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Urethra Transitional Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Malignant Renal Pelvis Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Ureter Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Urethra Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Papaverine
Non-Small Cell Lung Carcinoma
Ohio State University Comprehensive Cancer Center
P1
CC
(43)
Papaverine
Rectum Adenocarcinoma
City of Hope Medical Center
P1
CC
(43)
Papaverine
Lung Cancer
Ohio State University Comprehensive Cancer Center
P1
CC
(43)
Papaverine
Rectal Cancer
City of Hope Medical Center
P1
CC
(43)
Pas-004 Capsules
Neurofibromatosis Type 1
Pasithea Therapeutics Corp.
P1
CC
(43)
Pas-004 Tablets
Neurofibromatosis Type 1
Pasithea Therapeutics Corp.
P1
CC
(43)
Pazopanib
Cancer Or Benign Tumor
National Cancer Institute (NCI)
P1
CC
(43)
Pbf-1129
Non-Small Cell Lung Carcinoma
Dwight Owen
P1
CC
(43)
PBR111
Traumatic Brain Injury
University of North Carolina, Chapel Hill
P1
CC
(43)
P-Cd19Cd20-Allo1
Diffuse Large B-Cell Lymphoma
Poseida Therapeutics, Inc.
P1
CC
(43)
P-Cd19Cd20-Allo1
Follicular Lymphoma
Poseida Therapeutics, Inc.
P1
CC
(43)
Pcna Inhibitor Aoh1996
Leiomyosarcoma
City of Hope Medical Center
P1
CC
(43)
Pcna Inhibitor Aoh1996
Acute Myeloid Leukemia
City of Hope Medical Center
P1
CC
(43)
Pcna Inhibitor Aoh1996
Synovial Sarcoma
City of Hope Medical Center
P1
CC
(43)
Pebezertinib
Adenocarcinoma
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Chemotherapy-Induced Toxicity
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Bronchial Neoplasm
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Bronchogenic Carcinoma
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Lung Cancer
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Respiratory System Disorder
Blueprint Medicines Corporation
P1
CC
(43)
Showing 3126 to 3150 of 9,922 assets
Previous
Page 126 of 397
Next
